NAAG sent a letter to U.S. Senate committee leadership calling on them to quickly pass legislation (S.2456 and S.2440) that would increase penalties on opioid manufacturers that fail to report suspicious transactions and maintain effective controls against diversion of their drugs to the illicit market.
Connect with NAAG and the Attorney General Community
Create a NAAG account to subscribe to our newsletters or mailing lists.
